Fermenta Biotech Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming investor meeting. The intimation is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company, through its officials, will be participating in a one-to-one meeting with investors. The meeting details are as follows:
- Date: July 29, 2026
- Type of meeting: One-to-one meeting
- Mode: Physical
- Location: Mumbai
The disclosure specifically states that no unpublished price sensitive information (UPSI) is intended to be discussed during this interaction. All relevant press releases and investor presentations proposed to be discussed are already available on the company's website (www.fermentabiotech.com) and on BSE Limited's website (www.bseindia.com).
The company notes that changes to the meeting arrangements may occur due to exigencies on the part of either the company or the investors.